|
Newsletter 2025 July & August
2025年7&8月简报
|
About Us 国际微无创医学会简介
|
The International Society of Minimally Invasive and Virtual Surgery (ISMIVS, previously known as International Society of Minimally Invasive and Noninvasive Medicine) was founded in July 2013 at the gala of the 1st Yangtze International Summit of Minimally Invasive and Noninvasive Medicine in Chongqing, China. ISMIVS envisions to accelerating the progress in minimally invasive and noninvasive medicine by promoting research, education, communication, and international collaboration.
国际微无创医学会(ISMIVS)是在 2013 年 7 月在中国重庆召开的第一届国际微无创医学长江高峰论坛上宣布成立的,旨在通过学术研究、教育、交流以及国际合作加快微无创医学的发展。
|
Become a member 注册成为会员 >
|
Ideas about Young ISMIVS 医路青春专访栏目
|
Ideas about Young ISMIVS
医路青春专访栏目
|
|
In July 2023, the Young ISMIVS Committee was formally established in order to respond to the development trend of minimally invasive and noninvasive medicine, and further consolidate the core group of young physicians.
为顺应微无创医学发展的趋势,进一步凝聚中青年微无创医学骨干的力量,推动微无创医学的发展。2023年7月,国际微无创医学会“青年委员会”(以下简称“青委会”)正式成立。
As the youth force of the new era in the field of minimally invasive and noninvasive medicine, the Young ISMIVS Committee carries the important mission of enlightening medical innovation and leading the development of this field. It will become a solid pillar to promote the breakthroughs in minimally invasive and noninvasive medicine to new heights through its unique vitality and profound deposits.
青委会作为微无创领域新时代的青春力量,承载着启迪医学创新、引领微无创技术发展的重要使命,将凭借其独特的创新活力和深厚的专业积淀,成为推动微无创领域不断突破、迈向新高峰的坚实砥柱。
In medicine, a group of passionate young physicians, who harbor the love and persistence for minimal invasiveness and non-invasiveness, keep exploring and moving forward. They are the members of the Young ISMIVS Committee, who contribute to the development of this field with their enthusiasm and wisdom.
在医学的广阔天地里,这样一群热血的青年医者,他们怀揣着对微无创医学的热爱与执着,不断探索、不断前行。他们,正是青委会的成员,他们以青春的热情与智慧,为微无创医学的发展贡献着自己的力量。
In conjunction with Da Yi Wei Ke, we are now introducing the first interview show – Ideas about Young ISMIVS. Let's get closer to this group of young doctors, listen to their stories on the path of minimally invasive and non-invasive medicine, feel their passion and persistence, and witness the bright future together.
国际微无创医学会青年委员会联合大医微课策划出品,首档人物专访节目《医路青春》正在播出。让我们走近这群青年医者,聆听他们在微无创路上的成长故事,感受他们的热情与执着,共同见证微无创医学的辉煌未来。
Ideas about Young ISMIVS with:
本期嘉宾:
|
|
Dr. Xu Feng
Associate Chief Physician, Shijiazhuang Municipal People's Hospital
徐锋
石家庄市人民医院副主任医师
-Vice Chair of the Young ISMIVS Committee
-Chair-Elect of the Minimally Invasive Medicine Professional Committee, Hebei Medical Doctor Association
-Standing Committee Member, Non-Invasive Focused Ultrasound Technology Promotion Committee, China Maternal and Child Health Association
-Member of the Youth Study Group, Obstetrics and Gynecology Branch, Hebei Medical Association
国际微无创医学会青年委员会副主任委员
-河北省医师协会微无创专业委员会候任主任委员
-中国妇幼保健协会无创聚焦超声技术项目推广委员会常务委员
-河北省医学会妇产科分会青年学组委员
|
Watch the interview:
|
https://youtu.be/sPJIjY0UIhU
|
观看本期采访:
|
https://mp.weixin.qq.com/s/aFN5xUSrnuQvxFLEw4zcgQ
|
News 新闻
|
Keynote Session of ISMINIM 2025:
Advances and Future Directions of Minimally Invasive and Non-invasive Medicine
2025年峰会主旨讲座:微无创医学的发展与未来
|
|
|
The chairs of the keynote session are listed as following: Prof. Zhang Lian, the Director of Chongqing Haifu Hospital; Prof. Yuan Yufeng, the Vice President of Wuhan University and Head of the School of Medicine; Prof. Mohamed Hamed (Egypt), Cairo University; Prof. Felix Wong (Australia), the President of the China and Asia-Pacific Minimally Invasive Gynecologic Oncology Association (CA-AMIGO); Prof. Lu Man, the Vice President of Sichuan Cancer Hospital; Prof. Huang Haixin, the President of Liuzhou Workers' Hospital; Prof. Liang Jing, the Director of Obstetrics and Gynecology at China-Japan Friendship Hospital; Prof. Chen Chunlin of Nanfang Hospital, Southern Medical University; Prof. Zhao Renfeng, Guangxi Zhuang Autonomous Region People's Hospital; Prof. Choi Dong-suk, the President of Choi's Obstetrics and Gynecology Hospital (South Korea); Prof. He Min, Head of Training Department at National Engineering Research Center for Ultrasound Medicine; Dr. Sigit Pramono (Indonesia), Abdi Waluyo Hospital, Jakarta, Indonesia; Prof. Zhou Yufeng from the State Key Laboratory of Ultrasound in Medicine and Engineering; Prof. Vitaya Titapant, the Chair of the Royal Thai College of Obstetricians and Gynecologists; Prof. Zhao Jianfu, the Vice President of the First Affiliated Hospital of Jinan University; Dr. Chainarong Choksuchat from Prince of Songkla University Medical College, Thailand; and Dr. Zhang Cai from the State Key Laboratory of Ultrasound in Medicine and Engineering.
重庆海扶医院院长张炼、武汉大学副校长兼医学部部长袁玉峰、埃及开罗大学 Mohamed Hamed(埃及)、中国及亚太地区微创妇科肿瘤协会(CA-AMIGO)主席黄胡信(澳大利亚)、四川省肿瘤医院副院长卢漫、柳州市工人医院院长黄海欣、中日友好医院妇产科主任梁静、南方医科大学南方医院陈春林、广西壮族自治区人民医院赵仁峰、韩国崔氏妇产科医院院长崔铜硕(韩国)、超声医疗国家工程中心培训部主任何敏、印度尼西亚雅加达阿布迪•瓦鲁约医院院长 Sigit Pramono(印度尼西亚)、超声医学工程国家重点实验室周宇峰、泰国皇家妇产科学院主席 Vitaya Titapant(泰国)、暨南大学附属第一医院副院长赵建夫、泰国宋卡王子大学医学院 Chainarong Choksuchat (泰国)、超声医学工程国家重点实验室张彩等人担任主持。
|
|
|
-Prof. Mao Zhenbing: The role of regulatory science in guiding and supporting the high-quality development of focused ultrasound medical devices
Prof. Mao Zhenbin, the President of the China Food and Drug Quality Safety Promotion Association and Academician of the United Nations - International Academy of Ecological Life Safety Sciences, emphasized the pivotal role of regulatory science in advancing the standardized development of focused ultrasound medical devices. He proposed that a scientific regulatory system serves as the foundation for ensuring the safe innovation of medical technologies.
-毛振宾:监管科学引领支撑聚焦超声医疗器械高质量发展
中国食品药品企业质量安全促进会会长、联合国-国际生态生命安全科学院院士毛振宾强调了监管科学在推动聚焦超声医疗器械规范化发展中的关键作用,提出科学监管体系是保障医疗技术安全创新的基础。
-Prof. Philippe Descamps: Turning the tide in gynecologic surgery : From laparoscopy to HIFU
Philippe Descamps, President of the ISMIVS and Vice President of the International Federation of Gynecology and Obstetrics (FIGO), reviewed the evolution of gynecological surgery from traditional laparoscopy to HIFU technology, noting that minimally invasive techniques are progressively becoming the new standard for treating gynecological conditions.
-Philippe Descamps:妇科手术的变革:从腹腔镜到 HIFU
国际微无创医学会(ISMIVS)主席、国际妇产科联盟(FIGO)副主席 Philippe Descamps 回顾了妇科手术从传统腹腔镜到HIFU技术的变革历程,指出微无创技术正逐步成为妇科疾病治疗的新标准。
-Prof. Ji Xunming: Patient driven medical research
Prof. Ji Xunming, Academician of the Chinese Academy of Engineering delivered an online lecture, opening with stroke to advocate for a patient-centered approach to medical research. He emphasized that clinical medicine should place greater emphasis on patient experience and optimizing treatment outcomes.
-吉训明:患者驱动的医学研究
中国工程院院士吉训明线上讲座,以脑卒中开篇,倡导以患者需求为导向的医学研究模式,强调临床医学应更加关注患者体验和治疗效果优化。
-Prof. David Cranston: 25 years of HIFU in Oxford
Prof. David Cranston of the University of Oxford shared the team's 25 years of clinical experience with HIFU technology, demonstrating that its safety and efficacy in tumor treatment have been validated over the long term.
-David Cranston:牛津HIFU技术应用25年发展经历
英国牛津大学David Cranston教授分享了牛津大学 25 年HIFU技术的临床应用经验,证明该技术在肿瘤治疗中的安全性和有效性已得到长期验证。
-Prof. Chen Chunlin: Commit to sustained Innovation, build disciplinary brands, and embrace smart medicine
Prof. Chen Chunlin from Nanfang Hospital of Southern Medical University proposed that disciplinary development requires equal emphasis on technological innovation and brand building. Smart medicine and artificial intelligence will open up broader application prospects for minimally invasive techniques.
-陈春林:坚持持续创新 创建学科品牌 拥抱智慧医学
南方医科大学南方医院陈春林提出学科发展需要坚持技术创新与品牌建设并重,智慧医学、人工智能将为微无创技术带来更广阔的应用前景。
-Prof. Chyi-Long Lee: Charting the future - advances in minimally and non-invasive gynecology
Prof. Chyi-Long Lee, Chairman of the Board of APAGE, explored future trends in minimally invasive gynecological techniques, emphasizing the importance of multidisciplinary collaboration in advancing technological development.
-李奇龙:共塑未来:妇科微无创技术的发展
亚太妇科内窥镜和微创治疗协会(APAGE)董事会主席李奇龙教授探讨了妇科微无创技术的未来趋势,强调多学科协作对推动技术发展的重要性。
-Prof. Lv Ben: Technological innovation and new technology research and development help hospitals achieve high-quality development
Prof. Lv Ben, Vice President of the Second Xiangya Hospital of Central South University, analyzed the role of technological innovation in driving the hospital's high-quality development, emphasizing that new technology R&D serves as the core driving force for enhancing medical standards.
-吕奔:科技创新与新技术研发助力医院高质量发展
中南大学湘雅二医院副院长颜苗分析了科技创新对医院高质量发展的推动作用,指出新技术研发是提升医疗水平的核心动力。
-Prof. Wei Zhengqiang: The views of the Chinese Journal of Practical Gynecology and Obstetrics on new technologies
Prof. Wei Zhengqiang, Editor-in-Chief of the Chinese Journal of Practical Gynecology and Obstetrics, presented a cautious approach to emerging technologies from the perspective of academic journals, emphasizing that academic publications should guide the standardized application of such technologies.
-魏正强:浅谈医学创新研究——《中国实用妇科与产科杂志》对新技术的看法
中国实用妇科与产科杂志编辑部主任魏正强从学术期刊的角度介绍了对新兴技术的审慎态度,强调学术期刊应引导技术规范化应用。
-Prof. Felix Wong: Experience and insight into NIS in Gynaecology
Prof. Felix Wong, President of Liverpool Hospital, University of New South Wales, Australia, shared clinical experience in gynecological non-invasive surgery (NIS), asserting that minimally invasive techniques significantly reduce surgical trauma and accelerate recovery.
-黄胡信:妇科 NIS 的经验和见解
澳大利亚新南威尔士大学利物浦医院教授兼院长黄胡信分享了妇科非侵入性手术(NIS)的临床经验,认为微无创技术能显著降低手术创伤并加速康复。
-Prof. Vitaya Titapant: MINIM (Minimally Invasive and Noninvasive Medicine) - the changing agent for all
Prof. Vitaya Titapant, President of the Royal Thai College of Obstetricians and Gynaecologists, defines minimally invasive medicine as a revolutionary medium for medical practice, predicting it will profoundly transform future disease treatment approaches.
-Vitaya Titapant (泰国):微无创医学:改变一切的媒介
泰国皇家妇产科学院主席 Vitaya Titapant 将微无创医学定义为医疗模式的革命性媒介,预测其将深刻改变未来疾病治疗方式。
-Prof. Wang Shui: Basic research and clinical application of ablation techniques for breast diseases
Prof. Wang Shui from the Third Affiliated Hospital of Nanjing Medical University systematically outlined the theoretical basis of ablation techniques for breast diseases and validated the reliable efficacy of this technology through clinical case studies.
-王水:乳腺疾病消融技术的基础研究和临床应用
南京医科大学第三附属医院梁梦迪系统阐述了乳腺疾病消融技术的理论基础,并通过临床案例验证了该技术的可靠疗效。
-Prof. Lou Xin: Advances in MR-Guided focused ultrasound therapy for movement disorders
Prof. Xiong Yongqin from the First Medical Center of the PLA General Hospital demonstrated breakthrough advances in using magnetic resonance-guided focused ultrasound to treat Parkinson's disease and other movement disorders, offering a new option for neurosurgery.
-娄昕:磁共振引导聚焦超声治疗运动障碍疾病进展
解放军总医院第一医学中心熊永琴展示了磁共振引导聚焦超声在治疗帕金森等运动障碍疾病中的突破性进展,为神经外科提供新选择。
-Prof. Alan Matsumoto: Focused ultrasound for uterine fibroids & breast fibroadenomas and histotripsy for liver cancer
Professor Alan Matsumoto of the University of Virginia summarized the multiple advantages of focused ultrasound in treating uterine fibroids, breast fibroadenomas, and liver cancer, highlighting its precise ablation characteristics.
-Alan Matsumoto:聚焦超声治疗子宫肌瘤与乳腺纤维腺瘤及组织损毁术在肝癌治疗中的临床应用
弗吉尼亚大学健康医疗中心 Alan Matsumoto 教授总结了聚焦超声在子宫肌瘤、乳腺纤维腺瘤及肝癌治疗中的多重优势,突显其精准消融特性。
-Prof. Nguyen Viet Tien: Results of surgery application by high intensity confusion ultrasound(US-HIFU) at Thien An Maternity Hospital
Prof. Nguyen Viet Tien, former Deputy Minister of Health of Vietnam and current President of the Vietnamese Society of Obstetrics and Gynecology, presented clinical data from the application of USgHIFU technology at Vietnam's Thien An Obstetrics and Gynecology Hospital, confirming the technology's universal applicability across diverse populations.
-阮越进:善安妇产医院超声引导高强度聚焦超声(USgHIFU)临床应用结果分析
越南前卫生部副部长、现任越南妇产科学会主席阮越进报告了越南善安妇产医院应用USgHIFU技术的临床数据,证实该技术在不同人群中的普适性。
-Prof. Liu Ping: How to choose a treatment plan by accurately diagnosing pelvic organ prolapse
Liu Ping from Nanfang Hospital of Southern Medical University proposed personalized treatment plans for pelvic organ prolapse based on precise diagnosis, emphasizing the critical value of imaging assessments in surgical decision-making.
-刘萍:如何通过精准诊断盆腔脏器脱垂来选择治疗方案
南方医科大学南方医院刘萍提出基于精准诊断的盆腔脏器脱垂个体化治疗方案,强调影像学评估对手术决策的关键价值。
-Prof. Carlos Salazar: Impact of myomas, adenomyosis and endometriosis in infertility
Dr. Carlos Salazar, an obstetrician-gynecologist at a Spanish hospital, analyzed the mechanisms linking benign uterine conditions to infertility and recommended minimally invasive treatments as the preferred approach for preserving fertility.
-Carlos Salazar:子宫肌瘤、子宫腺肌症和子宫内膜异位症对不孕的影响
西班牙医院妇产科医生 Carlos Salazar 分析了子宫良性疾病与不孕症的关联机制,建议将微无创治疗作为生育功能保护的首选方案。
-Prof. Wang Zhibiao: Focused Ultrasound: a disruptive, frontier technology
Prof. Wang Zhibiao, Director of the State Key Laboratory of Ultrasound in Medicine and Engineering, defines high-intensity focused ultrasound as a disruptive technology, noting that its non-invasive and precise characteristics represent the future direction of medical development.
-王智彪:高强度聚焦超声:一个颠覆性、前沿性技术
超声医学工程国家重点实验室主任王智彪将高强度聚焦超声定义为颠覆性技术,指出其无创、精准的特性代表了未来医学的发展方向。
|
Watch the playback of the Summit:
|
https://www.youtube.com/playlist?list=PLWbjlVbxcLm3p9sE4xg3Z8YdcvZ4xOuYj
|
观看会议回放:
|
https://live.dayiweike.com/video/huikan/1980?m=jin
|
New Perspective in Focused Ultrasound 聚焦超声新视角
|
Inhibition of autophagy promotes ultrasound‑targeted microbubble destruction-induced apoptosis of pancreatic cancer cells
抑制自噬作用增强超声靶向微泡破坏对胰腺癌细胞的诱导凋亡作用
|
|
In therapeutic studies of pancreatic cancer, ultrasound-targeted microbubble destruction (UTMD) has shown potential in promoting apoptosis as a safe and non-invasive adjuvant therapy. The role of autophagy in UTMD-induced apoptosis in pancreatic cancer cells remains unclear.
|
在胰腺癌治疗研究中,超声靶向微泡破坏技术(UTMD)作为一种安全无创的辅助疗法,已被证明具有促进细胞凋亡的潜力。UTMD 诱导胰腺癌细胞凋亡过程中自噬的作用机制尚不清楚。
|
In this study, chloroquine (CQ), an autophagy inhibitor, was combined with UTMD to treat pancreatic cancer both in vitro and in vivo, with changes in apoptosis assessed through Western blot and TUNEL staining.
|
本研究采用自噬抑制剂氯喹(CQ)与 UTMD 联合治疗胰腺癌,并通过体外和体内实验评估其对细胞凋亡的影响,并采用蛋白质印迹和TUNEL染色技术检测凋亡相关蛋白的表达。
|
The results showed that UTMD induced both apoptosis and autophagy in pancreatic cancer cells.
|
结果表明,UTMD 可诱导胰腺癌细胞发生凋亡和自噬。
|
Read More >
|
Tech Update in Gynaecological Endoscopy 妇科腔镜技术最新进展
|
The impact of surgical intervention on time to conception and obstetric outcomes in women with endometriomas: a retrospective cohort study
手术干预子宫内膜异位瘤患者对受孕时间和产科结局的影响:一项回顾性队列研究
|
|
Lately, the author from Turkey published a retrospective study and 5444 patients are enrolled. The aim of this study was to compare the time to conception, mode of conception, and pregnancy outcomes between two groups of patients diagnosed with endometriomas: those managed conservatively and those who laparoscopic cystectomy.
最近,来自土耳其的作者发表了一项回顾性研究,招募了 5444 名患者。本研究的目的是比较两组诊断为子宫内膜异位瘤的患者:保守治疗组和腹腔镜膀胱切除术组的受孕时间、受孕方式和妊娠结局。
Their findings suggest that surgery prolongs the time to conception in patients with endometriomas; however, surgery does not influence the mode of conception, intrapartum pregnancy outcomes, mode of delivery, or timing of delivery. In the light of their findings, conservative approach can be considered as one of the first treatment choice in newly diagnosed patients with endometriomas who have no history of infertility and planning pregnancy.
他们的研究结果表明,手术延长了子宫内膜异位瘤患者的受孕时间;然而,手术不影响受孕方式、产时妊娠结局、分娩方式或分娩时间。根据他们的研究结果,保守方法可以被认为是新诊断的子宫内膜异位瘤患者的首选治疗选择之一,这些患者没有不孕史和计划怀孕。
In conclusion, clinical decision-making should take into account individual patient characteristics such as ovarian reserve, severity of disease and symptoms, and pregnancy plan to guide the need for surgical intervention in women with endometriomas. Further prospective studies, especially randomized controlled trials, are needed to validate the findings of this retrospective study.
总之,临床决策应考虑个体患者的特征,如卵巢储备、疾病和症状的严重程度以及妊娠计划,以指导子宫内膜异位瘤妇女是否需要手术干预。需要进一步的前瞻性研究,特别是随机对照试验来验证本回顾性研究的结果。
|
Read More >
|
|
|
|
|
|